肺癌疫苗应用现状与研制展望(4)
2.Shepherd FA. Alternatives to chemotherapy and radiotherapy in the treatment of small cell lung cancer.Semin Oncol. 2001 Apr;28(2 Suppl 4):30-7.
3.Allack MK, Sivanandham M, Balch CM, et al. Surgical adjuvant active specific immunotherapy for patients with stage Ⅲ melanoma: the final analysis of data from a phase Ⅲ, randomed double-blind, multicenter vaccinia melanoma oncolysate trial. J Am Coll Surg, 1998;187:69.
4.Grant SC, Kris MG, Houghton AN, et al. Long survival of patients with small cell lung cancer after adjuvant treatment with the anti-idiotypic antibody BEC2 plus Bacillus Calmette-Guerin. Clin Cancer Res. 1999 Jun;5(6):1319-23.
, http://www.100md.com
5.Dickler MN, Ragupathi G, Liu NX, et al. Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer. Clin Cancer Res. 1999 Oct;5(10):2773-9.
6.Shimizu K, Thomas EK, Giedlin M et al. Enhancement of tumor lysate- and peptide-pulsed dendritic cell-based vaccines by the addition of foreign helper protein. Cancer Res. 2001 Mar 15;61(6):2618-24.
7.Cao X, Zhang W, Wang J, et al. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells. Immunology. 1999 Aug;97(4):616-25.
, 百拇医药
8.Hung CF, Cheng WF, Chai CY, et al. Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen. J Immunol. 2001 May 1;166(9):5733-40.
9.Noguchi M, Imaizumi K, Kawabe T, et al. Induction of antitumor immunity by transduction of CD40 ligand gene and interferon-gamma gene into lung cancer. Cancer Gene Ther. 2001 Jun;8(6):421-9.
10.Hsu KF, Hung CF, Cheng WF, et al. Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen. Gene Ther. 2001 Mar;8(5):376-83.
, http://www.100md.com
11.Horig H, Lee DS, Conkright W,et al. Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule. Cancer Immunol Immunother. 2000 Nov;49(9):504-14.
12.Cheng WF, Hung CF, Chai CY,et al. Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J Clin Invest. 2001 Sep;108(5):669-78.
13.林苹，陆燕蓉，张洁，黄孝忠。表达B7分子的小鼠肺癌细胞的构建。免疫学杂志，2000;16(1):66-67.
14.林苹，陆燕蓉，张洁，黄孝忠，江映红。小鼠B7融合细胞的制备及生物学性质。中国肺癌杂志，2000;3(6):438-440., 百拇医药(黄邵洪，钟文昭，吴一龙，谷力加，翁毅敏，冯卫能，程超)
3.Allack MK, Sivanandham M, Balch CM, et al. Surgical adjuvant active specific immunotherapy for patients with stage Ⅲ melanoma: the final analysis of data from a phase Ⅲ, randomed double-blind, multicenter vaccinia melanoma oncolysate trial. J Am Coll Surg, 1998;187:69.
4.Grant SC, Kris MG, Houghton AN, et al. Long survival of patients with small cell lung cancer after adjuvant treatment with the anti-idiotypic antibody BEC2 plus Bacillus Calmette-Guerin. Clin Cancer Res. 1999 Jun;5(6):1319-23.
, http://www.100md.com
5.Dickler MN, Ragupathi G, Liu NX, et al. Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer. Clin Cancer Res. 1999 Oct;5(10):2773-9.
6.Shimizu K, Thomas EK, Giedlin M et al. Enhancement of tumor lysate- and peptide-pulsed dendritic cell-based vaccines by the addition of foreign helper protein. Cancer Res. 2001 Mar 15;61(6):2618-24.
7.Cao X, Zhang W, Wang J, et al. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells. Immunology. 1999 Aug;97(4):616-25.
, 百拇医药
8.Hung CF, Cheng WF, Chai CY, et al. Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen. J Immunol. 2001 May 1;166(9):5733-40.
9.Noguchi M, Imaizumi K, Kawabe T, et al. Induction of antitumor immunity by transduction of CD40 ligand gene and interferon-gamma gene into lung cancer. Cancer Gene Ther. 2001 Jun;8(6):421-9.
10.Hsu KF, Hung CF, Cheng WF, et al. Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen. Gene Ther. 2001 Mar;8(5):376-83.
, http://www.100md.com
11.Horig H, Lee DS, Conkright W,et al. Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule. Cancer Immunol Immunother. 2000 Nov;49(9):504-14.
12.Cheng WF, Hung CF, Chai CY,et al. Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J Clin Invest. 2001 Sep;108(5):669-78.
13.林苹，陆燕蓉，张洁，黄孝忠。表达B7分子的小鼠肺癌细胞的构建。免疫学杂志，2000;16(1):66-67.
14.林苹，陆燕蓉，张洁，黄孝忠，江映红。小鼠B7融合细胞的制备及生物学性质。中国肺癌杂志，2000;3(6):438-440., 百拇医药(黄邵洪，钟文昭，吴一龙，谷力加，翁毅敏，冯卫能，程超)